Intrarenal angiotensin II plays a powerful role in the pathogenesis of hypertension, with urinary angiotensinogen excretion rates potentially serving as an index of angiotensin II-dependent hypertension.
Intrarenal Ang II plays a powerful role in the pathogenesis of hypertension, and urinary angiotensinogen may serve as a biomarker for Ang II-dependent hypertension.
Intrarenal angiotensin II (Ang II) is regulated by several complex processes involving formation from both systemically delivered and intrarenally formed substrate, as well as receptor-mediated internalization. There is substantial compartmentalization of intrarenal Ang II, with levels in the renal interstitial fluid and in proximal tubule fluid being much greater than can be explained from the circulating levels. In Ang II--dependent hypertension, elevated intrarenal Ang II levels occur even when intrarenal renin expression and content are suppressed. Studies in Ang II--infused rats have demonstrated that augmentation of intrarenal Ang II is due, in part, to uptake of circulating Ang II via an Ang II type 1 (AT(1)) receptor mechanism and also to sustained endogenous production of Ang II. Some of the internalized Ang II accumulates in the light and heavy endosomes and is therefore potentially available for intracellular actions. The enhanced intrarenal Ang II also exerts a positive feedback action to augment intrarenal levels of angiotensinogen (AGT) mRNA and protein, which contribute further to the increased intrarenal Ang II in hypertensive states. In addition, renal AT(1) receptor protein and mRNA levels are maintained, allowing increased Ang II levels to elicit progressive effects. The increased intrarenal Ang II activity and AGT production are associated with increased urinary AGT excretion rates. The urinary AGT excretion rates show a clear relationship to kidney Ang II content, suggesting that urinary AGT may serve as an index of Ang II--dependent hypertension. Collectively, the data support a powerful role for intrarenal Ang II in the pathogenesis of hypertension.
Navar et al. (Fri,) conducted a review in Hypertension. Intrarenal Angiotensin II was evaluated. Intrarenal angiotensin II plays a powerful role in the pathogenesis of hypertension, with urinary angiotensinogen excretion rates potentially serving as an index of angiotensin II-dependent hypertension.